Circulating prostaglandin E2: A novel potential prognostic biomarker in patients with hepatocellular carcinoma. (March 2021) - Pelizzaro, F.; Kitenge, M.P.; Cardin, R.; Penzo, B.; Ponzoni, A.; Cillo, U.; Vitale, A.; Businello, G; Munari, G.; Fassan, M.; Farinati, F.